pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked · 1,831 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Marketed
trastuzumab deruxtecan
Enhertu (fam-trastuzumab deruxtecan-nxki)
Metastatic Colorectal Cancer
Receptor tyrosine-protein kinase erbB-2DNA topoisomerase 1
Daiichi Sankyo Co Ltd
13 catalysts
Marketed
encorafenib
Braftovi (encorafenib)
Metastatic Colorectal Cancer
Array BioPharma Inc
12 catalysts
Marketed
enfortumab vedotin
Padcev (enfortumab vedotin-ejfv)
Muscle Invasive Bladder Cancer (MIBC)
← prev
page 2 of 62
next →
131
Pain89
Neurology1
Nectin-4Tubulin
Astellas Pharma Inc
12 catalysts
Marketed
pentostatin
Pentostatin (pentostatin)
Hairy Cell Leukemia
Hikma Pharmaceuticals USA Inc
12 catalysts
Marketed
ANASTROZOLE
ANASTROZOLE (ANASTROZOLE)
Hormone Sensitive Breast Cancer
Stason Pharmaceuticals Inc
11 catalysts
Marketed
amivantamab
Rybrevant (amivantamab-vmjw)
Non-Small Cell Lung Cancer
Janssen Biotech Inc
11 catalysts
Marketed
erdafitinib
Balversa (erdafitinib)
Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer)
Fibroblast growth factor receptor
$JNJJOHNSON & JOHNSON
11 catalysts
Marketed
teclistamab
Tecvayli (teclistamab-cqyv)
Refractory Multiple Myeloma
Janssen Biotech Inc
11 catalysts
Marketed
dexamethasone
Hemady (dexamethasone [INN])
Multiple Myeloma (Kahler Disease)
Fera Pharmaceuticals LLC
10 catalysts
Marketed
LETROZOLE
LETROZOLE (LETROZOLE)
Breast Cancer
Yiling Pharmaceutical Ltd
9 catalysts
Marketed
rucaparib camsylate
Rubraca (rucaparib camsylate)
Epithelial Ovarian Cancer
PARP 1, 2 and 3
pharmaand GmbH
9 catalysts
Marketed
EXEMESTANE
EXEMESTANE (EXEMESTANE)
Metastatic Breast Cancer
$PFEPFIZER INC
8 catalysts
Marketed
Maxtrex
Methotrexate Sodium (methotrexate)
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia)
$PFEPFIZER INC
8 catalysts
Marketed
elranatamab
Elrexfio (elranatamab-bcmm)
Refractory Multiple Myeloma
T cell surface glycoprotein CD3Tumor necrosis factor receptor superfamily member 17
$PFEPFIZER INC
8 catalysts
Marketed
talquetamab
Talvey (talquetamab-tgvs)
Refractory Multiple Myeloma
G-protein coupled receptor family C group 5 member DT cell surface glycoprotein CD3
$JNJJOHNSON & JOHNSON
8 catalysts
Marketed
EPIRUBICIN HYDROCHLORIDE
EPIRUBICIN HYDROCHLORIDE (EPIRUBICIN HYDROCHLORIDE)
Breast Cancer
$AMRXAmneal Pharmaceuticals, Inc.
7 catalysts
Marketed
fedratinib
Inrebic (fedratinib)
Chronic Idiopathic Myelofibrosis (Primary Myelofibrosis)
Bristol-Myers Squibb Co
7 catalysts
Marketed
lorlatinib
Lorbrena (lorlatinib)
Non-Small Cell Lung Cancer
$PFEPFIZER INC
7 catalysts
Marketed
selinexor
Xpovio (selinexor)
Chronic Idiopathic Myelofibrosis (Primary Myelofibrosis)
Exportin-1
$KPTIKaryopharm Therapeutics Inc.
7 catalysts
Marketed
CINACALCET HYDROCHLORIDE
CINACALCET HYDROCHLORIDE (CINACALCET HYDROCHLORIDE)
Hypercalcemia
Slate Run Pharmaceuticals LLC
6 catalysts
Marketed
EVEROLIMUS
EVEROLIMUS (EVEROLIMUS)
Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast…
Novugen Pharma (Malaysia) Sdn Bhd
6 catalysts
Marketed
LEUCOVORIN CALCIUM
LEUCOVORIN CALCIUM (LEUCOVORIN CALCIUM)
Metastatic Colorectal Cancer
Avyxa Pharma LLC
6 catalysts
Marketed
lurbinectedin
Zepzelca (lurbinectedin)
Ewing Sarcoma
$JAZZJazz Pharmaceuticals plc
6 catalysts
Marketed
luspatercept
Reblozyl (luspatercept-aamt)
Anemia
Celgene Corp
6 catalysts
Marketed
pacritinib
Vonjo (pacritinib)
Chronic Idiopathic Myelofibrosis (Primary Myelofibrosis)
Sobi Inc
6 catalysts
Marketed
retifanlimab
Zynyz (retifanlimab-dlwr)
Squamous Non-Small Cell Lung Cancer
Programmed cell death protein 1
$INCYINCYTE CORP
6 catalysts
Marketed
(atezolizumab + hyaluronidase (human recombinant))
Tecentriq Hybreza ((atezolizumab + hyaluronidase-tqjs (human recombinant)))
Hepatocellular Carcinoma
Genentech Inc
5 catalysts
Marketed
(berahyaluronidase alfa + pembrolizumab)
Keytruda Qlex ((berahyaluronidase alfa-pmph + pembrolizumab))
Muscle Invasive Bladder Cancer (MIBC)
$MRKMerck & Co., Inc.
5 catalysts
Marketed
(hyaluronidase (recombinant, human) + nivolumab)
Opdivo Qvantig ((hyaluronidase-nvhy (recombinant, human) + nivolumab))
Adenocarcinoma Of The Gastroesophageal Junction
Bristol-Myers Squibb Co
5 catalysts
Marketed
POMALIDOMIDE
POMALIDOMIDE (POMALIDOMIDE)
Kaposi Sarcoma
Celgene Corp
5 catalysts